Cyber Monday Deal: Up to 60% off InvestingProCLAIM SALE

Norwegians want 14-month ban for 2010 Olympic champ Johaug

Published 11/29/2016, 07:40 AM
Updated 11/29/2016, 07:50 AM
© Reuters. FIS Tour de Ski overall women winner Johaug looks on during the podium ceremony, after the women's cross-country skiing 9km final climb free pursuit race on the Alpe Cermis

OSLO (Reuters) - Anti-Doping Norway has recommended a 14-month suspension for cross-country skier Therese Johaug following the former Olympic relay champion's positive test for clostebol, a banned anabolic steroid.

Johaug, 28, said in her defence that she used a medicine called Trofodermin, after consulting the national team doctor, to treat a sore on her lip and was unaware it contained a banned substance.

"We have recommended a 14-month ban and that will be sent to the disciplinary panel of the Norwegian Olympic Committee. I expect they will have a hearing in February," Anti-Doping Norway official Niels Kiaer told Reuters on Tuesday.

Johaug won the gold medal in the 4x5km relay at the Vancouver Olympics in 2010.

She also claimed a silver and bronze in Sochi four years later before winning three golds at the 2015 world championships in Sweden.

© Reuters. FIS Tour de Ski overall women winner Johaug looks on during the podium ceremony, after the women's cross-country skiing 9km final climb free pursuit race on the Alpe Cermis

If the Norwegian Olympic Committee accept the recommendation, Johaug's 14-month ban will be backdated to Oct. 18 when she was provisionally suspended.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.